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MaBACKGROUND The predictive value of ascending aortic distensibility (AAD) for mortality and hard cardiovascular
disease (CVD) events has not been fully established.
OBJECTIVES This study sought to assess the utility of AAD to predict mortality and incident CVD events beyond
conventional risk factors in MESA (Multi-Ethnic Study of Atherosclerosis).
METHODS AAD was measured with magnetic resonance imaging at baseline in 3,675 MESA participants free of overt
CVD. Cox proportional hazards regression was used to evaluate risk of death, heart failure (HF), and incident CVD in
relation to AAD, CVD risk factors, indexes of subclinical atherosclerosis, and Framingham risk score.
RESULTS There were 246 deaths, 171 hard CVD events (myocardial infarction, resuscitated cardiac arrest, stroke and CV
death), and 88 HF events over a median 8.5-year follow-up. Decreased AAD was associated with increased all-cause
mortality with a hazard ratio (HR) for the ﬁrst versus ﬁfth quintile of AAD of 2.7 (p ¼ 0.008) independent of age, sex,
ethnicity, other CVD risk factors, and indexes of subclinical atherosclerosis. Overall, patients with the lowest AAD had an
independent 2-fold higher risk of hard CVD events. Decreased AAD was associated with CV events in low to intermediate-
CVD risk individuals with an HR for the ﬁrst quintile of AAD of 5.3 (p ¼ 0.03) as well as with incident HF but not after full
adjustment.
CONCLUSIONS Decreased proximal aorta distensibility signiﬁcantly predicted all-cause mortality and hard CV events
among individuals without overt CVD. AAD may help reﬁne risk stratiﬁcation, especially among asymptomatic, low-
to intermediate-risk individuals. (J Am Coll Cardiol 2014;64:2619–29) © 2014 by the American College of Cardiology
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ABBR EV I A T I ON S
AND ACRONYMS
AAD = ascending aorta
distensibility
ABI = ankle-brachial index
CAC = coronary artery calcium
CMR = cardiac magnetic
resonance
CVD = cardiovascular disease
DBP = diastolic blood pressure
HDL = high-density lipoprotein
HF = heart failure
IMT = intima-media thickness
LVH = left ventricular
hypertrophy
MBP = mean brachial
blood pressure
PP = pulse pressure
PWV = pulse wave velocity
SBP = systolic blood pressure
Redheuil et al. J A C C V O L . 6 4 , N O . 2 4 , 2 0 1 4
Aortic Distensibility Predicting Mortality and CV Events D E C E M B E R 2 3 , 2 0 1 4 : 2 6 1 9 – 2 9
2620C onventional risk factors associatedwith atherosclerosis are major deter-minants of cardiovascular disease
(CVD). Recently, a complement to this classic
view was proposed and termed the vascular
aging continuum, starting from age-related
arterial stiffening leading to cardiac disease,
heart failure (HF), and microvascular disease
of the brain and kidneys, with resulting
disability and eventually death (1).SEE PAGE 2630The direct measurement of aortic stiffness
as a marker of early arterial damage may
be important. Although the usual onset of
CVD appears in middle and older age, a large
body of evidence suggests that subclinical
vascular and cardiac alterations start much
earlier in life (2–6). Global arterial stiffness
measured as carotid-femoral pulse wave
velocity (PWV) may independently predictincident CV events among patients as well as in the
general population separate from traditional CVD risk
factors (7). Subsequently, reference values and de-
terminants of PWV in healthy individuals, with and
without CVD risk factors, have been described for
large populations (8) and recently included in the
guidelines (9). In healthy humans, reduced ascending
aortic distensibility (AAD) as illustrated in Figure 1,
has been shown to be an early marker of subclinical
vascular alteration. However, little is known of the
prognostic value of altered proximal aortic function,
which is responsible for most of the mechanical
buffering and cushioning in the circulatory system,
thus inﬂuencing ventricular-vascular coupling (10).
Recently, Maroules et al. (11) reported modest asso-
ciations of aortic distensibility with a composite of
soft and hard CV endpoints in the Dallas Heart Study,
whereas thoracic aorta compliance, measured by
transesophageal echocardiography, may be compara-
bletocarotid-femoralPWVforpredictingmortality (12).
We postulated that a direct measure of aortic
function—AAD—using cardiac magnetic resonance
(CMR) imaging (13), may be directly related to hard
CV events and mortality, independent of classic CVD
risk factors. Thus, the aim of our study was to
determine the prognostic value of AAD beyond
established indexes of subclinical atherosclerosis
and conventional risk factors included in the global
Framingham risk score. To this end, we measured
aortic distensibility and ascertained the post-scan
occurrence of hard CVD events in participants
within the MESA (Multi-Ethnic Study of Atheroscle-
rosis) cohort.METHODS
MESA (14) is a population-based sample of 6,814 men
and women aged 45 to 84 years without clinical CVD
at the time of enrollment who identiﬁed themselves
as white, African American, Hispanic, or Chinese from
6 U.S. communities (Baltimore, New York, Minne-
apolis, Winston-Salem, Los Angeles, and Chicago).
Out of 5,098 participants who took part in the CV
CMR imaging examination, 3,675 subjects underwent
suitable AAD measurements for analysis. The study
was approved by the institutional review boards at all
recruiting ﬁeld centers, and all participants provided
written informed consent.
AORTIC AND CMR IMAGING. CMR imaging was per-
formed using 1.5-T whole-body magnetic resonance
imaging scanners as previously described (15). In
summary, gradient echo phase-contrast cine CMR
imaging with electrocardiographic gating was per-
formed to evaluate aortic distensibility. Images of the
ascending and descending aorta were obtained in the
transverse plane perpendicular to the aortic lumen at
the level of the right pulmonary artery. Imaging
parameters included repetition time of 10 ms, echo
time of 1.9 ms, ﬁeld of view of 34 cm, slice thickness
of 8 mm, matrix of 256  224, temporal resolution of
20 ms, encoding velocity of 150 cm/s, and bandwidth
of 32 kHz.
As illustrated in Figure 2, cross-sectional lumen
areas of the ascending aorta were determined using a
semi-automated contouring method with previously
reported interreader reproducibility (16). The
maximal (Amax) and minimal (Amin) aortic areas and
change in aortic area deﬁned as DA ¼ (Amax  Amin)
were used to calculate the AAD in each subject as
follows, with PP being pulse pressure (in mm Hg):
AAD ¼ DA/(Amin  PP) in 103 mm Hg1.
CMR imaging was performed with measure-
ments of left ventricular (LV) mass as previously
described (17).
CVD RISK FACTORS AND MEASURES OF SUBCLINICAL
ATHEROSCLEROSIS. During baseline examination, all
participants completed standardized questionnaires
to obtain information about smoking history, pack-
years of smoking, medication usage, diagnosis of
high cholesterol, and diabetes. Height and weight
were measured, and resting systolic (SBP) and dia-
stolic (DBP) blood pressures were measured 3 times
with an automated oscillometric sphygmomanometer
with participants in the seated position. The average
of the last 2 measurements was used in analysis.
Mean brachial blood pressure (MBP) was calculated
as: (2  DBP þ SBP)/3. The ankle-brachial pressure
FIGURE 1 Principle of Local Aortic Stiffness: Distensibility of the Ascending Aorta
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During systole, the ascending aorta stores most of the left ventricular stroke volume,
which is released downstream during diastole, thereby transforming a pulsatile ﬂow into a
steadier ﬂow. This cushioning effect allows minimizing energy expenditure. The relative
change in aortic lumen area divided by pulse pressure deﬁnes distensibility (A). Compar-
ative illustration of preserved (left) and altered (right) distensibility of the ascending aorta
(B) and corresponding cross-sectional area to cardiac cycle time curves for preserved
(blue) and altered (red) aortic distensibility (C).
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2621index (ABI) was calculated by dividing SBP at the
ankle by brachial SBP, as previously reported (18).
Heart rate was monitored and recorded at the time of
the CMR examination. Total and high-density lipo-
protein (HDL) cholesterol and glucose levels were
measured from blood samples obtained after a 12-h
fast. Diabetes mellitus was deﬁned as fasting
glucose $126 mg/dl or use of insulin or oral hypo-
glycemic medication. Among those without diabetes,
impaired fasting glucose was deﬁned as fasting
glucose from 100 to 125 mg/dl. Hypertension was
deﬁned as SBP $140 mm Hg, DBP $90 mm Hg, or
current use of antihypertensive medications. Carotid
artery intima-media thickness (IMT), a noninvasive
measure of subclinical atherosclerosis, was reported
to further characterize subclinical atherosclerosis. A
composite Z-score for overall maximal IMT was
calculated by summing the 2 carotid IMT sites after
normalization by the SD of each measure and divided
by the SD of the sum (19). IMT of the right and left
near and far walls of the common and internal carotid
artery were measured by B-mode echography. Mean
coronary artery calcium (CAC) score was measured by
computed tomography as previously described (19).
The sex-speciﬁc global CVD Framingham 10-year
risk score was calculated as described by D’Agostino
et al. (20), on the basis of these risk factors at base-
line: age, total cholesterol level, HDL cholesterol
level, SBP, antihypertensive treatment, smoking, and
diabetes.
FOLLOW-UP FOR CVD EVENTS AND DEATHS. Parti-
cipants were followed for death and incident CVD
events for an average 8.5 years from baseline exami-
nation. In addition to 4 follow-up MESA study ex-
aminations, a telephone interviewer contacted each
participant every 9 to 12 months to inquire about
all interim hospital admissions, CVD outpatient di-
agnoses, and deaths. Medical records were available
for an estimated 99% of hospitalized CVD events and
information was available on 97% of outpatient CVD
diagnostic encounters. Events and incidence dates
were adjudicated by 2 blinded physicians from the
MESA study events committee using pre-speciﬁed
criteria. Adjudication of events has been previously
detailed (17). Hard CVD events in the MESA trial were
required to be symptomatic and included myocardial
infarction, resuscitated cardiac arrest, stroke, and CV
death. Incident HF events were recorded. All deaths
were identiﬁed. For potential CVD deaths, cause was
assigned through committee review. For other
deaths, the underlying cause was obtained through
state or city vital statistics departments.
STATISTICAL ANALYSIS. Participant characteristics
were reported according to outcome as percentagesfor categorical variables and means and SD for
continuous variables. Baseline characteristics were
compared separately between both outcome groups
(death and incident CVD) and the group without
events using a Student t test for continuous variables
and a chi-square test for categorical variables.
The relationships between AAD and time-to-death/
time-to-CVD events and HF events were studied
using univariate and multivariate Cox regression
models. For the deﬁnition of time to death, subjects
who were alive before loss to follow-up were treated
as right censored. For the deﬁnition of time-to-CVD
or HF events, subjects who did not have events
(including CVD death) before loss to follow-up were
treated as right censored. Univariate Cox proportional
hazards regression models were ﬁrst ﬁtted for each
time to event (time to death, time to CVD, time to
HF) variable for quintiles of AAD without adjustment
of other covariates because the effects of AAD on the
hazard functions were nonlinear. Table 1 presents
distribution of AAD values in quintiles. Subsequently,
we studied the predictive value of AAD by quintiles
for mortality, hard CVD events, and HF events
compared with: 1) constitutional factors; 2) CV risk
factors; 3) measures of subclinical atherosclerosis
FIGURE 2 Measurement of Aortic Distensibility in MRI
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(A) Magnetic resonance imaging (MRI) shows 3-dimensional reconstruction of the thoracic aorta with transverse aortic dynamic acquisition plane (red). (B) Result of
the semi-automated segmentation of the ascending aorta (green contour). (C) Resulting cross-sectional area to cardiac cycle time curve.
TABLE 1 Distribution of AAD Values by Quintiles
AAD, 103 mm Hg1 Minimum 25% 50% 75% Maximum
AAD quintile 1 0.14 0.62 0.75 0.87 0.97
AAD quintile 2 0.97 1.06 1.15 1.25 1.34
AAD quintile 3 1.34 1.47 1.58 1.71 1.84
AAD quintile 4 1.84 2.00 2.16 2.35 2.60
AAD quintile 5 2.60 2.88 3.24 3.84 6.60
AAD ¼ ascending aorta distensibility.
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and 4) left ventricular hypertrophy (LVH). ABI was
considered abnormal when <1.0 or $1.4 as previously
determined to be related to outcome in the MESA trial
(18). LVH was deﬁned as LV mass $90th percentile in
the study population (197 g). We considered a 10-year
CVD risk to be low or intermediate when <10%,
corresponding to our cohort’s median risk, and high
when $10%.
Constitutional variables of adjustment for multi-
variate Cox regression models included age category,
sex, weight, height, and ethnicity. CV risk factors
used for further adjustment of the models included
MBP, antihypertensive medication (yes/no), dia-
betes (yes/no), total and HDL cholesterol levels, and
cigarette smoking in pack-years. Kaplan-Meier esti-
mates of the cumulative event-free distribution
functions were calculated for time to mortality and
time to CVD according to extreme quintiles of AAD.
Values of p < 0.05 were considered statistically
signiﬁcant. Conﬁdence intervals (CIs) were expressed
as 95% CIs. All analyses were performed using Stata
12C (StataCorp, College Station, Texas).
RESULTS
PARTICIPANT CHARACTERISTICS AND CVD RISK
PROFILE ACCORDING TO OUTCOME. Our analysis
included the 3,675 MESA participants who had aortic
distensibility measured by CMR imaging. There were
246 deaths, 171 hard CV events, and 88 incident HF
events over a median 8.5 years of follow-up. The
participants’ mean age at baseline was 60  10 years(range: 44 to 84 years). Of the participants, 54% were
female, 11% Chinese American, 29% African Amer-
ican, 17% Hispanic, and 43% white. Table 2 shows
baseline characteristics of participants according to
events. MESA participants with aortic data more often
tended to be white or African American and female
and overall have a moderately lower risk proﬁle and
subclinical atherosclerosis burden (IMT, ABI, CAC)
than participants without aortic CMR imaging.
Although statistically signiﬁcant in large population
samples, these differences do not seem to be within
clinically relevant ranges.
Overall, the most frequent hard CV events were
myocardial infarction (n ¼ 85), stroke (n ¼ 63), and CV
death (n ¼ 52) (multiple events possible). There was,
proportionally to the group without incident CVD or
death, an increased proportion of white individuals
among those who developed CVD and a higher pro-
portion of African Americans among those who died.
Subjects who died were older, more often male,
hypertensive, active smokers, and diabetic or with
TABLE 2 Baseline Characteristics of MESA Participants According to Outcome
Participants Without
Aortic CMR
(n ¼ 3,137)
Participants With
Aortic CMR
(n ¼ 3,675)
No Event
(n ¼ 3,316)
Deaths
(n ¼ 246) p Value†
Incident CVD
(n ¼ 171) p Value‡
Ethnicity, %
White 33 43* 43 40 0.33 52 0.013
Chinese American 13 11* 11 5 0.002 4 0.004
African American 26 29* 29 42 <0.001 29 0.87
Hispanic 28 17* 17 13 0.11 15 0.50
CV risk proﬁle
Age, yrs 64  10 61  10 60  10 69  10 <0.001 67  7 <0.001
Male/female, % 49/51 46/54* 44/56 57/43 <0.001 57/43 0.002
Height, cm 166  10 167  10 167  10 167  10 0.95 168  10 0.47
Weight, kg 80  19 78  16* 78  16 78  17 0.67 81  15 0.11
BMI, kg/m2 29  6 28  5* 28  5 28  5 0.60 29  5 0.15
Hypertension, % 49 42* 40 59 <0.001 63 <0.001
Hypertension medication, % 40 35* 33 51 <0.001 51 <0.001
Smoking status, %
Never 49 51 52 40 <0.001 47 0.26
Former 38 36* 35 38 0.12 30 0.35
Active 13 13 12 21 <0.001 23 <0.001
Diabetes status, %
Normal 68 78* 79 65 <0.001 63 <0.001
IFG 17 12* 11 17 0.004 13 0.54
Diabetes 15 10* 10 17 <0.001 22 <0.001
Total cholesterol, mg/dl 194  37 194  35 194  34 189  37 0.01 197  36 0.22
HDL cholesterol, mg/dl 50  14 52  15* 52  15 50  15 0.104 48  13 <0.001
Framingham 10-yr global risk, % 16.1  9.7 13.1  9.3* 12.3  8.9 20.5  9.4 <0.001 21.1  8.6 <0.001
Seated brachial blood pressures, mm Hg
SBP 129  22 125  21 124  21 133  25 <0.001 136  23 <0.001
DBP 72  10 72  10 72  10 72  11 0.96 75  11 <0.001
PP 57  18 53  17* 52  16 61  19 <0.001 61  18 <0.001
Mean BP 91  13 90  13 89  12 92  14 <0.001 95  14 <0.001
Brachial blood pressures during CMR, mm Hg
SBP n/a 134  21 133  20 144  23 <0.001 143  221 <0.001
DBP n/a 77  13 77  13 78  12 0.51 79  13 0.04
PP n/a 57  17 56  17 66  18 <0.001 64  17 <0.001
Mean BP n/a 96  14 96  14 100  14 <0.001 101  14 <0.001
Heart rate, beats/min 63.3  9.9 62.9  9.5* 62.8  9.3 63.9  11.1 0.09 64.5  10.8 0.03
Maximal internal carotid IMT, mm 0.89  0.20 0.86  0.18* 0.85  0.18 0.96  0.22 <0.001 0.92  0.17 <0.001
ABI 1.114  0.125 1.112  0.116* 1.118  0.107 1.045  0.179 <0.001 1.062  0.173 <0.001
CAC score, median (IQR) 5 (0–120) 0 (0–62)* 0 (0–42) 52 (0–300) <0.001 93 (10–308) <0.001
LV mass by CMR, g n/a 120  29 119  28 129  34 <0.001 130  32 <0.001
Ascending aortic function
AAD, 103 mm Hg1 n/a 1.86  1.31 1.91  1.34 1.36  0.69 <0.001 1.50  1.04 <0.001
Values are % or mean  SD. *p < 0.05 for the difference between groups with and without available aortic CMR imaging data in MESA. †p value for the signiﬁcance of
the difference between the group without events and the mortality group. ‡p value for the signiﬁcance of the difference between the group without events and the group
with incident CVD.
ABI ¼ ankle brachial index; BMI ¼ body mass index; BP ¼ blood pressure; CAC ¼ coronary artery calcium; CMR ¼ cardiac magnetic resonance; CVD ¼ cardiovascular;
CVD ¼ cardiovascular disease; DBP ¼ diastolic blood pressure; HDL ¼ high-density lipoprotein; IFG ¼ impaired fasting glucose; IMT ¼ intima-media thickness; IQR ¼ inter-
quartile range; LV ¼ left ventricular; n/a ¼ not applicable; PP ¼ pulse pressure; SBP ¼ systolic blood pressure; other abbreviation as in Table 1.
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2623impaired fasting glucose; body size, body mass index,
and heart rate were not different between the
2 groups. Subjects who died had slightly higher
total cholesterol levels but similar HDL cholesterol
levels and increased SBP and PP but similar DBP as
subjects without events. Subjects with incident CVDwere older, more often male, hypertensive, active
smokers, and diabetic, plus more likely to have
increased weight (þ10 kg on average) and body mass
index (þ1 point) than subjects without events.
Although total cholesterol levels were not increased
in the CVD group, HDL cholesterol levels were
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2624signiﬁcantly lower and all components of blood
pressure (SBP, DBP, and PP) were increased compared
with the group without events; heart rate was slightly
higher. AAD and ABI were lower, and carotid IMT,
CAC, and LV mass were signiﬁcantly higher in both
event groups compared with participants without
events (Table 2).
RELATIONSHIP OF AAD TO MORTALITY. The abso-
lute rate of death was 9.3% and incidence rate 0.04
per 1,000 person-years in participants with the lowest
levels of aortic distensibility (Q1) compared with 1.5%
and 0.003 per 1,000 person-years in participants with
the greatest aortic distensibility (Q5) (p < 0.001). The
Kaplan-Meier analysis (Central Illustration, upper
panel) showed a signiﬁcant decrease in survival in the
Q1 group compared with the group with the most
preserved aortic distensibility (p < 0.001). The dif-
ference in survival between Q1 and Q5 of AAD was
marked and consistently signiﬁcant over time. The
hazard ratio (HR) for death among Q1 participants was
signiﬁcantly increased at 6.5 compared with that of
the Q5 participants in univariate analysis (p < 0.001),
2.7 after adjustment for age, sex, ethnicity, and body
size and 2.7 after further adjustment for smoking,
antihypertensive medication, diabetes, and MBP (all
p < 0.01) (Table 3). This result was not substantially
changed after adjustment for brachial SBP or PP
instead of mean pressure. Furthermore, this result
remained consistent in the fully adjusted model after
further individual or grouped adjustment for ABI,
presence of CAC, carotid IMT, and presence of LVH
(all p # 0.01) (Table 3).
RELATIONSHIP OF AAD TO CVD EVENTS. The abso-
lute and incident rates of hard CVD were respectively
6.7% and 0.03 per 1,000 person-years in Q1 par-
ticipants compared with 1.4% and 0.005 per 1,000
person-years in Q5 participants (p < 0.001). The
Kaplan-Meier analysis showed a signiﬁcant decrease
in CVD-free survival in the Q1 group compared with
subjects with preserved aortic distensibility (Central
Illustration, lower panel). The difference in incident
CVD between Q1 and Q5 of AAD was constant,
notable, and signiﬁcant over time. However, some
degree of nonlinearity in HR distribution was present
across intermediate quintiles of AAD. The HR for CVD
in relationship to the degree of aortic stiffness is
summarized in Table 4.
Q1 participants had an unadjusted HR for incident
CVD of 5.7 (p < 0.001), 3.3 (p ¼ 0.002) after adjust-
ment for age, body size, and ethnicity, and 2.2 in the
fully adjusted model on CV risk factors including
MBP. A similar result was found after adjustment for
brachial SBP or PP instead of MBP.Overall, increased aortic stiffness predicted CVD in
the unadjusted and minimally adjusted models
independently of the individual effect of ABI, carotid
IMT, presence of CAC, or LVH (Table 4). In the fully
adjusted models, AAD remained predictive of CVD
after further adjustment for carotid IMT, which itself
was not a signiﬁcant predictor. However, AAD did
not reach signiﬁcance as a predictor of CVD when ABI
and CAC were added individually or together to the
fully adjusted models. Neither AAD nor LVH was a
signiﬁcant predictor in the fully adjusted models
when entered together.
When stratiﬁed according to Framingham risk
category (Table 5), AAD signiﬁcantly predicted CVD in
low- to intermediate-risk individuals (10-year CVD
risk <10%), with an HR of 8.9 (p ¼ 0.001) in univariate
analysis and 5.3 (p ¼ 0.03) in the fully adjusted
model, but did not reach signiﬁcance in high-risk
individuals (10-year CVD risk $10%). Additionally,
reduced aortic distensibility remained a signiﬁcant
predictor of incident CVD in the adjusted model in
low- to intermediate-risk individuals even after
further individual or grouped adjustment for ABI,
CAC, and carotid IMT and after individual adjustment
for LVH. Notably, ABI remained a signiﬁcant predictor
of CVD in low- to intermediate-risk individuals,
whereas CAC, carotid IMT, and LVH did not (Table 5).
Incident HF was associated with altered AAD
(Q1) in the univariate model, with an HR of 6.0 (95%
CI: 2.1 to 17.4; p ¼ 0.001), but this relationship failed
to reach signiﬁcance in the intermediate and fully
adjusted models (HR: 2.1; p ¼ 0.18 and HR: 1.4;
p ¼ 0.56, respectively).
DISCUSSION
We studied proximal aortic distensibility in a large
sample from the MESA study. Altered distensibility of
the ascending aorta was associated with increased
risk of: 1) all-cause mortality independent of age and
traditional CVD risk factors; and 2) incident CVD
independent of age and traditional CVD risk factors in
otherwise low- to moderate-risk participants. After
adjustment for traditional CV risk factors, individuals
with markedly altered AAD for their age group had a
2-fold increase in risk of all-cause death in compari-
son with individuals with preserved aortic distensi-
bility. Additionally, individuals with high aortic
stiffness had an almost 4-fold increase in risk
of incident CVD compared with individuals with
preserved aortic elasticity if they had a low- to
intermediate-risk CVD proﬁle at baseline. However,
high aortic stiffness only marginally predicted higher
levels of CVD in individuals with a high baseline CVD
CENTRAL ILLUSTRATION Cumulative Event-Free Probabilities for Survival and Survival Free of CVD
The cumulative event-free probabilities for survival (top) and survival free of incident hard cardiovascular disease (CVD) (bottom) display
similar patterns according to extreme quintiles of ascending aorta distensibility (AAD).
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TABLE 3 Relationship of Proximal Aortic Stiffness to Incident Mortality
Cox Models for All-Cause Mortality
Unadjusted Adjusted Model 1 Adjusted Model 2 Adjusted Model 3
HR (95% CI) p Value HR (95% CI) p Value HR (95% CI) p Value HR (95% CI) p Value
AAD quintile 1 6.5 (2.4–12.3) <0.001 2.7 (1.3–5.2) 0.005 2.7 (1.3–5.7) 0.008 2.3 (1.2–4.4) 0.009
AAD quintile 2 4.0 (2.1–7.7) <0.001 1.9 (1.0–3.9) 0.07 2.1 (0.9–3.0) 0.06 1.7 (0.9–3.3) 0.11
AAD quintile 3 4.1 (2.1–8.0) <0.001 2.5 (1.3–5.0) 0.007 2.6 (1.3–5.6) 0.01 2.2 (1.2–4.3) 0.01
AAD quintile 4 2.7 (1.4–5.5) 0.004 2.1 (1.0–4.2) 0.04 2.2 (1.1–4.7) 0.03 1.9 (1.0–3.7) 0.04
AAD quintile 5 1.0 (reference) 1.0 (reference)
ABI (<1.0 or $1.4) 2.6 (2.0–3.5) <0.001 2.1 (1.6–2.9) <0.001 1.9 (1.4–2.6) <0.001 1.8 (1.3–2.4) <0.001
AAD quintile 1 6.0 (3.3–10.7) <0.001 2.8 (1.5–5.1) 0.001 2.5 (1.3–4.7) 0.005
Carotid IMT 1.4 (1.3–1.6) <0.001 1.4 (1.2–1.6) <0.001 1.3 (1.2–1.5) <0.001 1.1 (0.6–2.3) 0.36
AAD quintile 1 2.2 (1.1–4.3) 0.02 2.3 (1.2–4.6) 0.01 2.5 (1.2–5.3) 0.01
CAC (present) 2.4 (1.8–3.3) <0.001 1.5 (1.0–2.1) 0.03 1.5 (1.1–2.1) 0.02 1.3 (1.0–1.9) 0.07
AAD quintile 1 5.0 (2.6–9.5) <0.001 2.5 (1.2–4.9) 0.009 2.7 (1.3–5.6) 0.009
LVH 1.6 (1.1–2.3) 0.02 1.7 (1.1–2.7) 0.01 1.7 (1.1–2.7) 0.01
AAD quintile 1 6.2 (3.3–11.7) <0.001 2.4 (1.2–4.7) 0.01 2.6 (1.2–5.5) 0.01
AAD quintile 1 corresponds to highest and quintile 5 to lowest aortic stiffness. Adjustment was performed for the following risk factors: model 1 ¼ age, sex, weight, height,
ethnicity; model 2 ¼ model 1 þ mean BP, smoking, antihypertensive medication, total cholesterol, HDL cholesterol, and diabetes; individual tests of AAD versus measures of
atherosclerosis ABI, carotid IMT, presence of CAC deﬁned as Agatston score >0, and LVH deﬁned as LV mass above 90th percentile are provided. Model 3 ¼ model 2 þ
adjustment for all measures of subclinical atherosclerosis (ABI, IMT, and CAC).
HR ¼ hazard ratio; LVH ¼ left ventricular hypertrophy; other abbreviations as in Tables 1 and 2.
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2626risk proﬁle. This is the ﬁrst report to demonstrate
independent association of aortic distensibility with
mortality and hard CVD events.
Important target organs, such as the heart and
brain, are directly linked both anatomically and
physiologically to the central elastic arterial sector
composed of the ascending aorta, aortic arch, and
carotid arteries. In this regard, the predictive value of
carotid-femoral PWV, a global estimate of arterialTABLE 4 Relationship of Proximal Aortic Stiffness to Incident Hard C
Cox M
Unadjusted Adjusted Mod
HR (95% CI) p Value HR (95% CI)
AAD quintile 1 5.7 (2.8–11.7) <0.001 3.3 (1.5–7.0)
AAD quintile 2 3.6 (1.7–7.5) 0.001 2.2 (1.0–4.8)
AAD quintile 3 3.6 (1.7–7.5) 0.001 2.6 (1.2–5.6)
AAD quintile 4 3.0 (1.4–6.3) 0.005 2.4 (1.1–5.2)
AAD quintile 5 1.0 (reference) 1.0 (reference)
ABI (<1.0 or $1.4) 2.5 (1.7–3.5) <0.001 2.2 (1.6–3.2)
AAD quintile 1 4.1 (2.2–7.6) <0.001 2.5 (1.3–5.0)
Carotid IMT 1.4 (1.2–1.6) <0.001 1.2 (1.0–1.4)
AAD quintile 1 4.7 (2.2–10.2) <0.001 3.4 (1.5–7.7)
CAC (present) 4.3 (2.9–6.5) <0.001 3.2 (2.1–5.0)
AAD quintile 1 3.9 (1.9–8.0) <0.001 3.0 (1.4–6.5)
LVH 1.8 (1.2–2.7) 0.009 1.6 (1.0–2.6)
AAD quintile 1 5.5 (2.7–11.3) <0.001 3.1 (1.4–56.8)
AAD quintile 1 corresponds to highest and quintile 5 to lowest aortic stiffness. Adjustme
ethnicity; model 2 ¼ model 1 þ mean BP, smoking, antihypertensive medication, total
of atherosclerosis ABI, carotid IMT, presence of CAC deﬁned as Agatston score>0, and
adjustment for all measures of subclinical atherosclerosis (ABI, IMT, and CAC).
Abbreviations as in Tables 1 to 3.stiffness, has been established in the general popu-
lation and in patients with CVD (7,10,21–23). The
importance of the proximal aorta in the buffering
function of systolic load and therefore in preserving
vascular-ventricular coupling is paramount (24–27).
Age is a main determinant of arterial structural and
functional changes, and subclinical alteration of
proximal aortic function can occur early. However,
the complex interplay between structural andVD
odels for Incident Hard CVD
el 1 Adjusted Model 2 Adjusted Model 3
p Value HR (95% CI) p Value HR (95% CI) p Value
0.002 2.2 (1.0–4.8) 0.04 1.9 (0.9–3.8) 0.09
0.05 1.8 (0.8–4.0) 0.14 1.8 (0.9–3.7) 0.10
0.01 2.2 (1.1–5.0) 0.04 1.9 (0.9–3.9) 0.07
0.02 2.2 (1.0–4.8) 0.04 1.9 (0.9–3.9) 0.07
<0.001 1.9 (1.3–2.7) 0.001 1.8 (1.2–2.5) 0.003
0.007 1.8 (0.9–3.5) 0.11
0.05 1.1 (0.9–1.3) 0.41 0.6 (0.2–1.5) 0.27
0.002 2.4 (1.1–5.5) 0.03
<0.001 3.0 (1.9–4.7) <0.001 2.7 (1.8–4.2) <0.001
0.004 2.1 (0.9–4.5) 0.07
0.05 1.6 (0.9–2.5) 0.07
0.004 2.1 (1.0–4.7) 0.06
nt was performed for the following risk factors: model 1 ¼ age, sex, weight, height,
cholesterol, HDL cholesterol, and diabetes; individual tests of AAD versus measures
LVH deﬁned as LV mass above 90th percentile are provided. Model 3 ¼ model 2 þ
TABLE 5 Relationship Between AAD and Incident Hard CVD According to Global Framingham Risk Category
Cox Models for Incident Hard CVD According to Risk Category
10-Year CVD risk <10% 10-Year CVD risk $10%
Unadjusted Adjusted* Unadjusted Adjusted*
HR (95% CI) p Value HR (95% CI) p Value HR (95% CI) p Value HR (95% CI) p Value
ABI (<1.0 or $1.4) 4.7 (2.1–10.4) <0.001 5.4 (2.2–13.0) <0.001 1.9 (1.3–2.8) 0.001 1.6 (1.1–2.4) 0.02
AAD quintile 1 6.7 (2.1–22.1) 0.001 5.8 (1.6–21.2) 0.008 1.7 (0.8–3.6) 0.17 1.3 (0.6–2.9) 0.52
Carotid IMT 1.7 (1.0–2.9) 0.03 1.6 (0.9–2.9) 0.09 1.2 (1.0–1.4) 0.05 1.0 (0.9–1.2) 0.71
AAD quintile 1 7.0 (1.8–26.9) 0.005 4.7 (1.1–20.6) 0.04 2.5 (1.0–6.5) 0.05 2.0 (0.7–5.4) 0.18
CAC (present) 2.6 (1.2–5.7) 0.02 2.1 (0.9–5.1) 0.11 3.6 (2.2–5.9) <0.001 3.3 (1.9–5.6) <0.001
AAD quintile 1 7.8 (2.1–29.6) 0.003 5.0 (1.2–21.7) 0.03 2.1 (0.9–5.0) 0.09 1.6 (0.7–4.1) 0.30
ABI þ IMT þ CAC† — — — — — — — —
AAD quintile 1 6.3 (1.9–20.8) 0.003 5.8 (1.6–21.1) 0.008 1.8 (0.8–4.0) 0.16 1.5 (0.6–3.5) 0.37
LVH 2.7 (0.8–9.2) 0.10 4.8 (1.0–22.5) 0.05 1.3 (0.8–2.1) 0.21 1.5 (0.9–2.5) 0.15
AAD quintile 1 9.5 (2.3–34.9) 0.001 5.0 (1.2–22.1) 0.03 2.3 (1.0–5.4) 0.05 1.6 (0.6–4.2) 0.30
Quintile 1 corresponds to highest and quintile 5 to lowest aortic stiffness. *Fully adjusted model on age, sex, weight, height, ethnicity, mean BP, smoking, antihypertensive
medication, total cholesterol, HDL cholesterol, and diabetes. †ABI, carotid IMT, and CAC were entered together in the otherwise unadjusted and fully adjusted models.
Abbreviations as in Tables 1 to 3.
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2627functional changes in both the aorta and left
ventricle through vascular-ventricular coupling is
mainly driven by the aging process and further
aggravated by atherosclerosis, the prevalence of
which also increases with age. The proximal aorta
dilates and elongates during normal aging secondary
to structural wall changes that include thinning and
fragmentation of elastin ﬁbers within the media.
This process ultimately leads to arterial stiffness and
increased afterload on the left ventricle, with
consequent LVH and systolic and diastolic dysfunc-
tion (26,27). Hundley et al. (28) showed the rela-
tionship between aortic stiffness and impaired
exercise capacity in the elderly and Fernandes et al.
(4) showed the relationship between increased ca-
rotid stiffness and subclinical alteration in LV sys-
tolic and diastolic myocardial deformation in the
MESA study.
Aortic dilation and elongation associated with
aortic stiffening (29) lead to a static aortic volume
increase partly compensating for the loss of proximal
aortic elasticity (systolic cushioning function and
diastolic recoil) (Figure 1). Until advanced age, or
earlier as a result of lifelong aggravating factors such
as hypertension, diabetes, or CVD, both aortic and
LV function decline proportionally such that the
vascular-ventricular coupling is preserved. However,
when aortic stiffness is very high, aortic and cardiac
complications may occur secondary to a sharp
increase in arterial load. This may explain in part why
this study and others have found extreme aorta
stiffness values to be the most relevant in predicting
adverse outcomes. However, a speciﬁc cutpoint has
not been deﬁned.Additionally, ﬂow alterations secondary to large-
artery structural and functional modiﬁcations are
transmitted to smaller arteries and may lead to car-
diac, cerebral, and renal microvascular damage and
subsequent target organ failure. The resulting global
vascular aging continuum may account for the strong
association between altered AAD and all-cause
mortality beyond CVD’s speciﬁc role.
Our results are consistent with those of prior
studies on global measures of aortic stiffness, such as
the Framingham community-based data of Mitchell
et al. (21), regarding superiority of a direct measure of
aortic stiffness over conventional brachial SBP or PP
to predict all-cause mortality or incident CVD over
time. However, we did not assess the relative value of
central versus peripheral blood pressure in this rela-
tionship. Additionally, we have found that the high-
est stiffness group is the most signiﬁcantly related to
adverse outcome, with an unevenly graded rela-
tionship between outcome and degree of stiffness in
intermediate stiffness categories. We found the
comparison of the highest and lowest quintiles of
AAD to be consistently and strongly different over
time in relation to outcome, whereas quintiles 2
through 4 exhibited some degree of crossing between
cumulative event curves in the initial half of the
follow-up period.
Although direct comparison is not possible with
results from the meta-analysis of Vlachopoulos et al.
(7) on predicting all-cause mortality and incident CVD
because of differing predictor variables (PWV vs.
AAD), categorization, and adjustment, it is interesting
to note that our ﬁndings are consistent. In particular,
the relative risk for all-cause mortality was 1.9 (95%
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE:
Proximal aortic stiffness can be assessed by cardiac
magnetic resonance imaging and is an important
determinant of circulatory efﬁciency. Alterations in
proximal aortic function are an early marker
of cardiovascular aging, atherosclerosis, and other
forms of cardiovascular disease.
TRANSLATIONAL OUTLOOK: Longitudinal studies
are needed to assess the relative value of various in-
dexes of aortic and vascular function, including
distensibility, as predictors of clinical outcomes.
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2628CI: 1.60 to 2.24) in their study versus an HR of 2.3 in
the present study. In contrast, however, they found
marked stiffness to confer higher risk in the subgroup
with a higher baseline risk than in low-risk in-
dividuals. This can be explained by the notably
different deﬁnition of risk and sample selection.
Indeed, the high-risk group in the Framingham
cohort included subjects with known coronary artery
disease, renal disease, hypertension, and diabetes,
whereas our large sample of the MESA cohort,
although representative of MESA participants overall,
included participants without overt CVD, fewer
subjects with diabetes, and no participants with
end-stage renal disease. Compared with results by
Maroules et al. (11) using CMR imaging in a general
population sample of the Dallas Heart Study, HRs
relating AAD to CV outcome were higher in our study.
This may best be explained by somewhat lower power
due to a relatively lower sample size (n ¼ 2,122) and
follow-up time in a generally younger cohort with
lower prevalence of CV risk factors yielding fewer
events than in the MESA trial. Furthermore, primary
endpoint deﬁnition was signiﬁcantly different be-
tween studies; the primary composite endpoint in
Maroules et al. (11) included soft events (hospitaliza-
tions for unstable angina, atrial ﬁbrillation, revascu-
larization), whereas we focused only on hard events.
A powerful general CV risk assessment score pre-
dicting 10-year risk for CVD in the Framingham study
has been established for primary care use (20). Our
study showed that AAD is a strong predictor of inci-
dent CVD and, therefore, is a potentially useful
risk evaluation criterion in low- to intermediate-risk
individuals; its value in high-risk individuals is
more limited. We found that belonging to the highest
aortic stiffness category was signiﬁcantly related to
incident CVD, with an HR of 1.9 when the global CV
risk score integrating all traditional risk factors was
considered and 2.4 when individuals with 10-year
CVD risk <10% was considered. Furthermore, when
all risk factors were studied individually or together,
AAD remained an independent predictor of CVD in
the low- to intermediate-risk subcohort, albeit not
among those with a baseline global risk score $10%.
STUDY LIMITATIONS. Not all participants in the
MESA study had aortic CMR images, and so our study
was limited to a subgroup of 3,677 of 5,098 partici-
pants (72%) who had a CMR examination and 3,677 of
6,814 (54%) of the whole MESA cohort. Risk factors
were slightly less prevalent in the subgroup of MESA
participants with aortic distensibility data compared
with other participants. Nevertheless, this remains
the largest reported sample of proximal aorta dis-
tensibility using CMR imaging in any population.Additionally, the semi-automated contour registra-
tion process used to determine aortic areas during the
cardiac cycle required a degree of manual interven-
tion, and future studies may beneﬁt from automated
segmentation methods. Finally, the number of events
remains relatively low and available data lack the
statistical power to allow us to discriminate the
potential predictive value of AAD for individual
events such as HF in this cohort.
CONCLUSIONS
Decreased AAD signiﬁcantly predicted all-cause mor-
tality and incident CVD events among individuals
without overt CVD. The predictive value of proximal
aortic stiffness for CVD was highest in subjects with
low to intermediate global CV risk in whom risk eval-
uation could be useful. These ﬁndings support the
hypothesis that the loss of proximal aortic distensi-
bility is an important early marker of the vascular ag-
ing continuum intertwined with atherosclerosis
leading to subclinical target organ damage and ulti-
mately increased morbidity and mortality.
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